Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00067041
Recruitment Status : Terminated
First Posted : August 13, 2003
Last Update Posted : March 7, 2013
Information provided by (Responsible Party):
United Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2003
  Study Completion Date : December 2003